Literature DB >> 16632008

Isolated Brucella peritonitis in a CAPD patient.

Lale Ozisik1, Beril Akman, Bulent Huddam, Ozlem Kurt Azap, Ayse Bilgic, Siren Sezer, Nurhan Ozdemir.   

Abstract

Peritonitis is the most common complication in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Brucellosis is a rare cause of bacterial peritonitis. Only 1 case was reported of a patient with brucella peritonitis during CAPD therapy. In that case, CAPD peritonitis was accompanied by acute brucellosis. We present the case of a patient with isolated brucella peritonitis receiving CAPD therapy without systemic manifestations of brucellosis who works as a farmer. Results of a serum agglutination test and blood cultures were negative; however, the patient's peritoneal fluid agglutination titer was 1:160 and samples inoculated into BACTEC (Becton Dickinson, NJ) bottles yielded Brucella melitensis. Because we were unable to isolate the organism in blood samples, transmission seems to be the result of direct inoculation, rather than hematogenous spreading. Therefore, our patient represents the first case of isolated brucella peritonitis during CAPD therapy. Successful treatment was obtained by using a treatment regimen of rifampin and doxycycline.

Entities:  

Mesh:

Year:  2006        PMID: 16632008     DOI: 10.1053/j.ajkd.2006.01.028

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

Review 1.  Brucella peritonitis in peritoneal dialysis: a case report and review of the literature.

Authors:  Yalcin Solak; Zeynep Biyik; Sinan Demircioglu; Ilker Polat; Nejdet Genc; Kultigin Turkmen; Suleyman Turk
Journal:  Perit Dial Int       Date:  2012 Mar-Apr       Impact factor: 1.756

2.  Brucella canis peritonitis.

Authors:  H Javeri; S Jamieson; R Sehgal; J Cadena
Journal:  Infection       Date:  2013-07-12       Impact factor: 3.553

3.  Brucella Peritonitis in a Patient on Peritoneal Dialysis: A Case Report and Review of Literature.

Authors:  Saeed M Al Zabali; Aljawharah K Rubaihan; Madawi F Alnetaifat; Salem Alshahrani; Moza Alhammadi
Journal:  Cureus       Date:  2021-12-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.